Lanfen An
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Hongbo Wang (12 shared papers)Jun Zhang (10 shared papers)Rui Shi (11 shared papers)Sitian Wei (9 shared papers)Zhicheng Yu (9 shared papers)Qi Zhang (2 shared papers)Rong Zhao (5 shared papers)Dilu Feng (5 shared papers)
- Journals
- Molecular Carcinogenesis (2 papers)BMC Cancer (2 papers)Cell Death Discovery (1 paper)Journal of Cellular Physiology (1 paper)Cancers (1 paper)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Lanfen An
14 papers receiving 295 citations
Lanfen An's Hit Papers
Peers
Comparison fields: 5 of 46
- Cancer Research 112
- Obstetrics and Gynecology 28
- Molecular Biology 154
- Reproductive Medicine 14
- Pulmonary and Respiratory Medicine 50
Countries citing papers authored by Lanfen An
This map shows the geographic impact of Lanfen An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanfen An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanfen An more than expected).
Fields of papers citing papers by Lanfen An
This network shows the impact of papers produced by Lanfen An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanfen An. The network helps show where Lanfen An may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanfen An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma Hit paper breakdown → | 2024 | 90 |
| 2 | 2022 | 40 | |
| 3 | 2022 | 35 | |
| 4 | 2021 | 31 | |
| 5 | 2020 | 23 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 15 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 11 | |
| 10 | 2023 | 8 | |
| 11 | 2022 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 1 | |
| 15 | 2026 | 0 |
About Lanfen An
Lanfen An is a scholar working on Cancer Research, Obstetrics and Gynecology, Molecular Biology, Cell Biology and Oncology, having authored 15 papers that have together received 298 indexed citations. Recurring topics across this work include Circular RNAs in diseases (2 papers), Microtubule and mitosis dynamics (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers), RNA Research and Splicing (2 papers), Epigenetics and DNA Methylation (2 papers), Ubiquitin and proteasome pathways (2 papers) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (112 citations), Obstetrics and Gynecology (28 citations), Molecular Biology (154 citations), Reproductive Medicine (14 citations) and Pulmonary and Respiratory Medicine (50 citations). Lanfen An has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Hongbo Wang, Jun Zhang, Rui Shi, Sitian Wei, Zhicheng Yu, Qi Zhang, Rong Zhao, Dilu Feng, Xing Zhou and Jiarui Zhang. Their work appears in journals such as Molecular Carcinogenesis, BMC Cancer, Cell Death Discovery, Journal of Cellular Physiology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.